21 October 2026
FOPH: Poison Information Centre: Government seeks to secure long-term Funding through Legislation
On 21 October 2026, the Federal Council has opened a consultation on amendments to the Chemicals Act and the Therapeutic Products Act aimed at securing the long-term financing of Tox Info Suisse, Switzerland’s national poison information centre. Following unsuccessful discussions with representatives of the chemical and pharmaceutical industries on a voluntary funding arrangement, the Federal Council proposes requiring manufacturers of chemicals and marketing authorisation holders of medicinal products to contribute to the operation and financing of the centre. The proposal reflects the fact that chemical products and medicines account for more than 70 per cent of poisoning cases handled by Tox Info Suisse, which responds to around 40’000 enquiries annually. Approximately 5’500 chemical companies and 300 pharmaceutical companies would be affected, with average annual contributions of around CHF 240 and CHF 5’300 respectively. The consultation period runs until 8 February 2027.
For more information, see here.
More News
-
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: Haemovigilance Annual Report 2025
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Global regulators call for advancing alternatives to animal testing
-
Swissmedic: Changes to the Guidance document “Import of a human medicinal product according to art. 14 para. 2 and 3 TPA (parallel import)”